Teva's CEO talks Q4 earnings and how he is implementing his 'pivot to growth' strategy

(6:52)

Teva Pharmaceuticals CEO talks Trump and US healthcare

(5:43)

Teva Pharma CEO: Majority of momentum came from innovative business, not GLP-1s

(4:3)

Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement

(2:26)

Tel Aviv-based Teva CEO: Our manufacturing is unaffected as it stands

(4:14)

Future Teva CEO Seeks to 'Formulate Clear Strategy'

(2:34)

Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations

(8:51)

Teva Pharmaceuticals CEO Talks \

(4:30)

Teva CEO Talks Drug Pricing, Generics, Supply Shortages | Bloomberg Talks

(7:9)

TEVA 2023-01 CFO and new CEO at JPM

(31:34)

'You cannot critique us for trying to help,' says Teva CEO on sustainability-linked bond launch

(2:50)

Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz

(11:7)

Richard Francis, CEO at Teva, joins NYSE Floor Talk to discuss its new Pivot to Growth strategy

(6:4)

Teva Pharma CEO: We see a stable U.S. market place for our generics

(4:6)

Teva CEO Sees Signs Volumes Are Getting Back to Normal

(7:35)

Teva CEO Richard Francis on Q2 earnings beat

(3:4)

Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel

(3:35)

Teva 2022-01 CEO at JPM Conf

(30:30)

Teva Pharmaceutical Industries, Celebrates Transfer to New York Stock Exchange from NASDAQ

(43)

TEVA Pharmaceutical Industries Limited Visits the NYSE

(1:4)